Aldara, Imiquimod News

Imiquimod Treatment of Lentigo Maligna: An Open-Label Study of 34 Primary Lesions in 32 Patients Urs V. Buettiker, MD ; Nikhil Y. Yawalkar, MD ; Lasse R. Braathen, MD, PhD, MHA ; Robert E. Hunger, MD, PhD Arch ...

“Dose-ranging studies demonstrated early on that the current percentage is sufficient for clinical benefit with associated but tolerable side effects”

Topical imiquimod's potential uses appear to be ever-expanding, with case reports of successful treatment for conditions ranging from keratoacanthoma, keloid and lentigo maligna to molluscum contagiosum. via Dermatology Times

Berkeley, Calif. &#8212 Vivicare, a direct-to-patient education company, is teaming up with Graceway Pharmaceuticals to provide product marketing services for Aldara , PharmaLive reports. via Dermatology Times

“Doctors, patients and pharmaceutical companies all win by achieving shared goals like improved patient satisfaction and increased compliance with treatment regimens.”

Vivacare will provide Graceway Pharmaceuticals with physician and product marketing services in support of Aldara . via Rehab Management

Graceway Pharmaceuticals Reports Study in New England Journal of Medicine: ALDARA Cream, 5% demonstrated a reduction in lesion size in patients with vulvar intraepithelial neoplasia BRISTOL, Tenn. via Earth Times

Apr 16, 2008 - Graceway Pharmaceuticals, LLC today announced the results from a study comparing 3 different treatments for actinic keratosis, a skin condition that can become cancerous if left untreated. via Med Ad News

“We consider imiquimod the first-choice treatment for vulvar intraepithelial neoplasia.”

A topical cream effectively reduces lesion sizes and clears human papillomavirus in vulvar intraepithelial neoplasia, according to a New England Journal of Medicine study. via Journal Watch - Medicine that Matters

“Imiquimod is effective in the treatment of vulvar intraepithelial neoplasia”

WEDNESDAY, April 2 -- An imiquimod cream is effective in treating vulvar intraepithelial neoplasia, reducing lesion size, itching and pain, according to a report in the April 3 issue of the New England Journal ... via Dermatology Times

The literature varies on the pigmentary changes induced by topical use of imiquimod. via CiteULike